China Feihe Limited (CFEIY)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY bn | 19 | 23 | 21 | 20 | 21 | 18 | 18 | 18 |
| Operating profit | CNY bn | 3 | 3 | ||||||
| Net profit | CNY bn | 7 | 7 | 5 | 3 | 4 | 2 | 2 | - |
| EPS reported | CNY | 2.10 | 2.00 | ||||||
| Operating cashflow per share | CNY | 2.45 | 2.39 | ||||||
| Capex per share | CNY | 1.74 | 0.98 | ||||||
| FCF per share | CNY | 0.71 | 1.41 | ||||||
| Free cash flow | CNY bn | 1 | 1 | ||||||
| Net debt | CNY bn | -16 | -15 | ||||||
| Book value equity | CNY bn | 24 | 24 | ||||||
| Book value per share | CNY | 27.02 | 27.55 | ||||||
| Number of shares | m | 904.93 | 881.73 | ||||||
| DPS (TTM paid) | CNY | 2.22 | 1.82 |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 17.45 | - | ||||||
| P/B LTM | x | 1.35 | 1.36 | ||||||
| P/S LTM | x | 1.88 | 1.83 | ||||||
| P/FCF LTM | x | 51.42 | 26.65 | ||||||
| EV/EBITDA LTM | x | 7.87 | 7.73 | ||||||
| EV/Sales LTM | x | 1.49 | 0.81 | ||||||
| Earnings Yield LTM | % | +5.73% | +8.33% | ||||||
| FCF Yield | % | +1.94% | +3.75% | ||||||
| Quality | |||||||||
| ROE | % | +7.72% | +7.29% | ||||||
| ROIC | % | +6.38% | +5.17% | ||||||
| Operating margin | % | +16.18% | +12.04% | ||||||
| Gross margin | % | +65.01% | +64.73% | ||||||
| FCF/Sales | % | +3.65% | +6.78% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -46.15% | -48.72% | ||||||
| Sales Growth YoY | % | -15.08% | -12.98% | ||||||
| Net Income Growth YoY | % | -47.16% | -50.99% | ||||||
| FCF Growth | % | -76.01% | -53.72% | ||||||
| Operating Profit Growth | % | -48.78% | -51.56% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +6.79% | +8.81% | ||||||
| Dividend Growth | % | -25.47% | -38.85% | ||||||
| Payout Ratio | % | +118.23% | +1.19% | ||||||
| FCF/Debt | x | 0.75 | 2.29 | ||||||
| Net Debt/EBITDA | x | -2.04 | -1.98 | ||||||
| EBIT/Net interest | x | 92.26 | 90.42 | ||||||
| Net debt/market cap | % | +2.22% | +1.97% | ||||||
| Net debt/Equity | x | -0.64 | -0.62 | ||||||
| Gross debt/equity | x | 0.04 | 0.02 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
China Feihe Limited functions as an investment holding company, primarily specializing in the manufacturing and distribution of infant milk formula throughout Mainland China and the United States. The firm's product range is extensive, including various milk products such as raw milk, adult milk powders, and liquid milk, alongside a selection of health care products. Furthermore, it supplies specialized options like soybean and goat milk powders. Beyond dairy, China Feihe also engages in the retail of a wide array of nutritional supplements, including vitamins, minerals, and herbal products. Its sales strategy utilizes multiple channels, reaching customers through a network of distributors, prominent e-commerce platforms like Tmall, JD.com, and Suning.com, and directly via its corporate website and mobile applications, notably WeChat. As of December 31, 2021, the company maintained a substantial offline distribution infrastructure, serving approximately 2,000 direct customers who, in turn, managed a vast network of 110,000 retail points of sale. Established in 1962, China Feihe Limited has its corporate headquarters located in Beijing, People's Republic of China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
China Feihe Limited functions as an investment holding company, primarily specializing in the manufacturing and distribution of infant milk formula throughout Mainland China and the United States. The firm's product range is extensive, including various milk products such as raw milk, adult milk powders, and liquid milk, alongside a selection of health care products. Furthermore, it supplies specialized options like soybean and goat milk powders. Beyond dairy, China Feihe also engages in the retail of a wide array of nutritional supplements, including vitamins, minerals, and herbal products. Its sales strategy utilizes multiple channels, reaching customers through a network of distributors, prominent e-commerce platforms like Tmall, JD.com, and Suning.com, and directly via its corporate website and mobile applications, notably WeChat. As of December 31, 2021, the company maintained a substantial offline distribution infrastructure, serving approximately 2,000 direct customers who, in turn, managed a vast network of 110,000 retail points of sale. Established in 1962, China Feihe Limited has its corporate headquarters located in Beijing, People's Republic of China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free